Antonio C Fuentes-Fayos Selected Research

Buformin

1/2021	Clinical, Cellular, and Molecular Evidence of the Additive Antitumor Effects of Biguanides and Statins in Prostate Cancer.
1/2019	Biguanides Exert Antitumoral Actions in Pituitary Tumor Cells Through AMPK-Dependent and -Independent Mechanisms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonio C Fuentes-Fayos Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2019
6	Pituitary Neoplasms (Pituitary Adenoma) 01/2022 - 01/2019
5	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 10/2019
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 12/2020
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2020 - 06/2019
3	Prolactinoma (Prolactinomas) 01/2020 - 01/2019
2	Glioma (Gliomas) 01/2022 - 12/2020
1	Obesity 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 10/2021
1	Breast Neoplasms (Breast Cancer) 10/2021
1	Carcinogenesis 08/2021
1	Pituitary ACTH Hypersecretion 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 12/2020
1	Hyperlipidemias (Hyperlipidemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Acromegaly 06/2019

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2019
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2020
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 06/2019
4	Hormones (Hormone)IBA 01/2020 - 01/2019
3	pladienolide BIBA 01/2022 - 01/2019
3	Metformin (Glucophage)FDA LinkGeneric 10/2021 - 01/2019
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2022 - 12/2020
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 01/2021
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2020
2	GhrelinIBA 01/2022 - 11/2021
2	BuforminIBA 01/2021 - 01/2019
2	Phenformin (Fenformin)IBA 01/2021 - 01/2019
2	BiguanidesIBA 01/2021 - 01/2019
2	RNA Splicing FactorsIBA 12/2020 - 01/2020
1	CateninsIBA 01/2022
1	pasireotideIBA 01/2022
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022
1	ProlactinIBA 01/2022
1	somatostatin receptor type 1IBA 01/2022
1	ElementsIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 11/2021
1	Insulin (Novolin)FDA Link 11/2021
1	AMP-Activated Protein KinasesIBA 10/2021
1	somatotropin releasing hormone receptorIBA 08/2021
1	Growth Hormone-Releasing Hormone (Somatotropin Releasing Hormone)IBA 08/2021
1	Lovastatin (Mevacor)FDA LinkGeneric 01/2021
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 06/2020
1	MicroRNAs (MicroRNA)IBA 06/2020
1	Growth Hormone (Somatotropin)IBA 06/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2021
1	Drug Therapy (Chemotherapy) 10/2021
1	Castration 01/2020